Comment on "Crotalidae Polyvalent Immune Fab and Cost-Effective Management of Hospital Admissions for Snakebites"

Am Surg. 2022 Jun;88(6):1379-1380. doi: 10.1177/00031348221078965. Epub 2022 Apr 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antivenins
  • Cost-Benefit Analysis
  • Hospitals
  • Humans
  • Immunoglobulin Fab Fragments
  • Snake Bites* / therapy

Substances

  • Antivenins
  • Crotalidae Polyvalent immune Fab
  • Immunoglobulin Fab Fragments